CDKN1A and liver cancer: However, both JMJD2A plus P21WAF1/Cip1 and JMJD2A plus Pim1RNAi did significantly not alter the BrdU positive rate of liver cancer cells (39.52 ± 9.08%, 36.46 ± 8.02% versus34.01 ± 6.32%, p = 0.16246 > 0.05, P = 0.0683 > 0.05, respectively) (Figure 8C).